Kidney disorder
Therapeutic area
Nephrology
Rare disease
No
- Definition
- A disease involving the kidney.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Kidney disorder
- Therapeutic area
- Nephrology
- kidney disorder
- disease of kidney
- disease or disorder of kidney
- disorder of kidney
- kidney disease
- kidney disease or disorder
- kidney disorder
- renal disease
- renal disorder
- All therapeutic areas
- Nephrology
- Severity
- Severe
- MONDO ID
- MONDO:0005240
- Parent condition
- MONDO:0002118
Related records
Broader conditions (4)
- Disease
- Disease by body system or component
- Human disease
- Urinary system disorder
Narrower conditions (556)
- Acquired cystic disease-associated renal cell carcinoma
- Acquired distal renal tubular acidosis
- Acquired Fanconi syndrome
- Acute diffuse glomerulonephritis
- Acute kidney injury
- Acute kidney tubular necrosis
- Acute papillary necrosis
- Acute poststreptococcal glomerulonephritis
- Acute proliferative glomerulonephritis
- Acute pyelonephritis
- Acute tubulointerstitial nephritis
- Acute urate nephropathy
- Adenovirus renal infection
- Adrenal cortex carcinoma
- Adrenocortical carcinoma, hereditary
- Adult familial nephronophthisis-spastic quadriparesia syndrome
- Adult Fanconi syndrome
- Adult kidney Wilms tumor
- ALG9-associated autosomal dominant polycystic kidney disease
- Alport syndrome
Trials (1,041)
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
- 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
- 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers
- A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants
- A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus
- A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
- A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg
- A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy
- A Communication Tool to Assist Older Adults Facing Dialysis Choices
- A Comparative Study Between the Usage of Flexible and Navigable Suction Ureteral Access Sheath Versus Traditional Access Sheath in Retrograde Intrarenal Surgeries
- A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)
- A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria
- A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
- A Dietitian-Driven Unified Nutritional Care Model (ADDUCE)
- A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
- A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma
- A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
- A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
- A Multi-Center, Open-Label Study
Approved drugs (3)
- Bumetanide
- Losartan potassium
- Sevelamer hydrochloride
Drugs in development (250)
- Abrocitinib Phase 1
- Acetaminophen Phase 3
- Acetazolamide Phase 2
- Acetylcysteine Phase 2
- Acyclovir sodium Phase 1
- Albumin human Phase 2
- Aldafermin Phase 1
- Alemtuzumab Phase 1
- Aliskiren Phase 2
- Allopurinol Phase 2
- Amlodipine Phase 1
- Angiotensin Phase 3
- Aprocitentan Phase 1
- Arginine Early phase 1
- Asciminib Phase 1
- Atorvastatin Phase 3
- Avanafil Phase 1
- Avasopasem manganese Phase 1
- Azathioprine Phase 3
- AZD5672 Phase 1
Other linked drugs (6)
- Alteplase
- Aminohippurate sodium
- Calcifediol
- Fondaparinux
- Icodextrin
- Tesevatinib